Acoramidis Improves Cardiac Function in Transthyretin Amyloid Cardiomyopathy

Acoramidis, a next-generation TTR stabilizer, shows promising results in improving cardiac function and promoting regression in Transthyretin Amyloid Cardiomyopathy. The ATTRibute-CM Cardiac Magnetic Resonance Substudy evaluated changes in cardiac structure, function, and amyloid burden after treatm

0 views • 8 slides